| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $-0.0B |
| EPS (Basic) | $0.43 | $0.66 | $1.43 | $1.21 | $0.90 | $-0.26 |
| EPS (Diluted) | $0.43 | $0.66 | $1.43 | $1.21 | $0.90 | $-0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $30.6B | $25.6B | $21.1B | $22.6B | $23.5B | $16.0B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — |
| Total Liabilities | $26.2B | $21.9B | $18.2B | $20.2B | $20.1B | $12.5B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $4.3B | $3.6B | $3.0B | $2.5B | $3.4B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.4B | $1.1B | $2.4B | $-1.1B | $-2.0B | $-2.4B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-1.0B | $-2.1B | $-0.2B | $1.0B | $4.0B |